EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Pfizer (PFE) Stock Moves Despite Drug Development Halt
Pfizer Inc (PFE) in FPA Queens Road Value Fund Q2 2024
Pfizer (NYSE:PFE) Trading 1.2% Higher - Here's What Happened
Bladder Cancer Advocacy Network Announces National Presenting Sponsorships by Ferring Pharmaceuticals and the Astellas/Pfizer Alliance for the 2025 Walks to End Bladder Cancer | Morningstar
Pfizer Inc. (NYSE:PFE) Shares Purchased by Schwerin Boyle Capital Management Inc.
Pfizer on Pace for Largest Percent Increase Since December 2024 - Data Talk | Morningstar
Haleon Takes Full Control Of Chinese Consumer Healthcare Venture
8,784 Shares in Pfizer Inc. (NYSE:PFE) Bought by Rossby Financial LCC
Pfizer Inc. (NYSE:PFE) Stock Position Lifted by XTX Topco Ltd
Pfizer Inc. (NYSE:PFE) Position Boosted by CreativeOne Wealth LLC
Pfizer Inc. (NYSE:PFE) Stake Boosted by CreativeOne Wealth LLC
Pfizer (PFE) Abandons Obesity Drug Trial Due to Safety Concerns
Pfizer (PFE) Halts Trial of GLP-1 Pill Due to Safety Concerns
Why Pfizer scrapped obesity pill development: Weight-loss drug market - Healthcare News | The Financial Express
Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation
Counterfeit Ozempic in U.S. Drug Supply; Oral GLP-1 Axed; Food Additives and T2D | MedPage Today
Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)
Pharmaceutical Stocks To Add to Your Watchlist - April 14th
Pfizer halts development of weight loss pill after liver injury report
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/4IESDYW32BH6XG37WGZVBHSKWY.jpg)
Pfizer: Discontinuation of Obesity Drug Candidate Danuglipron Has No Effect on Our Valuation | Morningstar
Pfizer Discontinues Development of Oral GLP-1 Receptor Agonist Danuglipron
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/HE2XT5SV5ZBU5MOM6PPYWRIGP4.png)
10 Best Blue-Chip Stocks to Buy for the Long Term | Morningstar
Wegovy, Zepbound makers' stocks rally as a weight-loss-drug competitor drops out | Morningstar
Pfizer's Obesity Setback Puts Pressure on CEO to Make a Deal
U.S. Stocks Close: Tech Tariffs Temporarily Suspended, Three Major Indices Rise Collectively, Chinese Stocks Gain Broadly | SMM
Pfizer Inc. (PFE): "Dead Money… Close the Casket," Says Jim Cramer
Invion: Revolutionizing Photodynamic Therapy (PDT) for Cancer, Infectious Diseases | INN
Obesity Drug Developers Rise on M&A Hopes After Pfizer Setback
Broyhill Asset Management Makes New $231,000 Investment in Pfizer Inc. (NYSE:PFE)
Viking Therapeutics (VKTX) Gains Attention After Pfizer's Setback | PFE Stock News
Pfizer (PFE) Exits GLP-1 Race: Impact on Eli Lilly, Novo Nordisk, and Viking Therapeutics
Pfizer (PFE) Halts Obesity Drug Development Amid Safety Concerns | PFE Stock News
Viking Therapeutics (VKTX) Shares Surge After Pfizer's Danuglipron Halt | GPCR Stock News
Pfizer's (PFE) Halt on Drug Boosts Prospects for Structure Therapeutics (GPCR) | GPCR Stock News
Pfizer will stop development of daily weight-loss pill danuglipron | Fox Business
Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds?
Pfizer's $130B Weight-Loss Dream Just Collapsed
Pfizer scraps weight loss pill after liver injury: What it means for the future of obesity drugs? - The Economic Times
Pfizer (PFE) Ends Development of Danuglipron, Market Reaction Expected to be Mild | PFE Stock News
News Highlights: Top Company News of the Day - Monday at 9 AM ET | Morningstar
Jim Cramer's top 10 things to watch in the stock market Monday
Pfizer (PFE) Stock Drops After Halting Obesity Drug Development
Pfizer ends development of promising obesity pill after safety concerns | India News - Business Standard
Pfizer halts development of weight-loss pill | Company Business News
3Chopt Investment Partners LLC Decreases Stake in Pfizer Inc. (NYSE:PFE)
dow jones futures rise: US stock market prediction today: Market futures rise - Dow Jones, S&P 500, and Nasdaq set to surge as Trump exempts tech devices from tariffs - Apple, Nvidia lead gains; major banks report mixed Q1 results - The Economic Times
Pfizer Discontinues Development of Weight-Loss Pill Danuglipron Following Liver Injury Incident
Pfizer (PFE) Halts Development of Weight Loss Drug Danuglipron
Pfizer (PFE) Halts Development of Obesity Drug Danuglipron | PFE Stock News
Synovus Financial Corp Sells 149,616 Shares of Pfizer Inc. (NYSE:PFE)
Stamos Capital Partners L.P. Raises Holdings in Pfizer Inc. (NYSE:PFE)
TT Capital Management LLC Buys New Holdings in Pfizer Inc. (NYSE:PFE)
Pfizer Halts Development Of Oral Weight-Loss Pill After Liver Injury Case In Patient
Pfizer Discontinues Weight-Loss Pill Danuglipron
Pfizer Inc (PFE) Discontinues Development of Danuglipron for Weight Management | PFE stock news
Pfizer ends development of weight-loss pill danuglipron
Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron | PFE Stock News
Pfizer abandons obesity pill after liver injury in major setback
Pfizer Shares Slip After Company Scraps Weight-Loss Pill | Morningstar
Pfizer scraps daily weight loss pill danuglipron after a liver injury
Townsquare Capital LLC Cuts Holdings in Pfizer Inc. (NYSE:PFE)
Sagespring Wealth Partners LLC Takes Position in Pfizer Inc. (NYSE:PFE)
Pfizer ends development of potential pill obesity treatment | TribLIVE.com
Pfizer scraps planned weight loss pill
Pfizer Discontinues Development Of Danuglipron
Pfizer's loss offers boost to competitors in obesity space | BioWorld
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey
11 Best Dividend Paying Stocks to Buy According to Hedge Funds
The Motley Fool: Pfizer rates as a dividend giant
Bessemer Group Inc. Sells 21,371 Shares of Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Heritage Trust Co Takes Position in Pfizer Inc. (NYSE:PFE)
Oak Associates Ltd. OH Lowers Holdings in Pfizer Inc. (NYSE:PFE)
Is Pfizer Inc. (PFE) A Cheap NYSE Stock to Invest in According to Hedge Funds?
This energy stock will 'pay you while you wait' during volatility: Miller Tabak's Maley
3-Stock Lunch: Chevron, Pfizer and Amazon.com
Pfizer (NYSE:PFE) Trading Down 3.9% - Time to Sell?
Pfizer Inc. (NYSE:PFE) Shares Purchased by Summit Financial Wealth Advisors LLC
Pfizer Inc. (NYSE:PFE) Shares Sold by First Foundation Advisors
Pfizer Inc. (NYSE:PFE) Shares Sold by Legacy Financial Advisors Inc.
Neuberger Berman Group LLC Cuts Stock Position in Pfizer Inc. (NYSE:PFE)
LSV Asset Management Acquires 807,215 Shares of Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Shares Sold by Scotia Capital Inc.
DRW Securities LLC Acquires Shares of 33,096 Pfizer Inc. (NYSE:PFE)
Conservatives, NDP target Liberals on campaign trail | Watch News Videos Online
RFK Jr.'s purge of FOIA staff at FDA Spares people working on covid vaccine lawsuits
Sen. Johnson demands COVID vaccine makers hand over all documents, communications, as evidence against their products reaches a climax - NaturalNews.com
Longitudinal voice monitoring in a decentralized Bring Your Own Device trial for respiratory illness detection
Neuberger Berman Group LLC Has $131.18 Million Holdings in Pfizer Inc. (NYSE:PFE)
Pfizer Inc (PFE) Announces Virtual 2025 Annual Meeting of Shareholders
Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24 | ...
Pfizer (NYSE:PFE) Trading Down 2.7% on Analyst Downgrade
ELCO Management Co. LLC Sells 13,321 Shares of Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Shares Bought by FIL Ltd
Clive Palmer-supported vaccine injury case 'incoherent', 'unintelligible' and 'ambiguous'
CERE Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Filed on Behalf of Former CERE Shareholders | Markets Insider
Trajectories of sleep disturbance and self-management of chronic conditions during COVID-19 among middle-aged and older adults
ATCodeR: a dictionary-based R-tool to standardize medication free-text
Latest news
Stock market today: Most Asian stocks fell after US equities declined
MicroStrategy joins Nasdaq-100 index: MSTR stock performance analysis 2024
Morning Note: Tesla Soars, AUDUSD Hits Key Support, Oil & SP500 Insights
Nikkei 225 up 1.39%: Japanese Stocks Rise Following Yen's Continued Weakness
